Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1989 Jul;64(7):1017–1021. doi: 10.1136/adc.64.7.1017

Screening for Duchenne muscular dystrophy.

R A Smith 1, M Rogers 1, D M Bradley 1, J R Sibert 1, P S Harper 1
PMCID: PMC1792699  PMID: 2629623

Abstract

A programme was introduced in Wales to screen all 18 month old boys who were not yet walking for raised creatine kinase activity within the existing community developmental screening programme. During an 18 month period 25 229 such boys were identified of whom 19 930 (79%) had a Denver developmental screening test and 338 (1.7%) of these were not walking. Two hundred and five of those who did not walk (61%) had creatine kinase activity assayed and two cases of Duchenne muscular dystrophy were detected. We conclude that screening boys of 18 months who do not walk is worthwhile if the opportunity arises, but that a population based screening programme of this type is not justified as detection rates will be unacceptably low.

Full text

PDF
1017

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bryant G. M., Davies K. J., Newcombe R. G. The Denver Developmental Screening Test. Achievement of test items in the first year of life by Denver and Cardiff infants. Dev Med Child Neurol. 1974 Aug;16(4):475–484. doi: 10.1111/j.1469-8749.1974.tb03372.x. [DOI] [PubMed] [Google Scholar]
  2. Cole C. G., Walker A., Coyne A., Johnson L., Hart K. A., Hodgson S., Sheridan R., Bobrow M. Prenatal testing for Duchenne and Becker muscular dystrophy. Lancet. 1988 Feb 6;1(8580):262–266. doi: 10.1016/s0140-6736(88)90349-2. [DOI] [PubMed] [Google Scholar]
  3. Crisp D. E., Ziter F. A., Bray P. F. Diagnostic delay in Duchenne's muscular dystrophy. JAMA. 1982 Jan 22;247(4):478–480. [PubMed] [Google Scholar]
  4. Dellamonica C., Collombel C., Cotte J., Addis P. Screening for neonatal Duchenne muscular dystrophy by bioluminescence measurement of creatine kinase in a blood sample spotted on paper. Clin Chem. 1983 Jan;29(1):161–163. [PubMed] [Google Scholar]
  5. Dellamonica C., Robert J. M., Cotte J., Collombel C., Dorche G. Systematic neonatal screening for Duchenne muscular dystrophy. Lancet. 1978 Nov 18;2(8099):1100–1100. doi: 10.1016/s0140-6736(78)91836-6. [DOI] [PubMed] [Google Scholar]
  6. Drummond L. M. Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy. Arch Dis Child. 1979 May;54(5):362–366. doi: 10.1136/adc.54.5.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Forrest S. M., Smith T. J., Cross G. S., Read A. P., Thomas N. S., Mountford R. C., Harper P. S., Geirsson R. T., Davies K. E. Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy. Lancet. 1987 Dec 5;2(8571):1294–1297. doi: 10.1016/s0140-6736(87)91192-5. [DOI] [PubMed] [Google Scholar]
  8. Frankenburg W. K., Dodds J. B. The Denver developmental screening test. J Pediatr. 1967 Aug;71(2):181–191. doi: 10.1016/s0022-3476(67)80070-2. [DOI] [PubMed] [Google Scholar]
  9. Gardner-Medwin D., Bundey S., Green S. Early diagnosis of Duchenne muscular dystrophy. Lancet. 1978 May 20;1(8073):1102–1102. doi: 10.1016/s0140-6736(78)90949-2. [DOI] [PubMed] [Google Scholar]
  10. Gardner-Medwin D. Recognising and preventing Duchenne muscular dystrophy. Br Med J (Clin Res Ed) 1983 Oct 15;287(6399):1083–1084. doi: 10.1136/bmj.287.6399.1083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Goodship J., Malcolm S., Robertson M. E., Pembrey M. E. Service experience using DNA analysis for genetic prediction in Duchenne muscular dystrophy. J Med Genet. 1988 Jan;25(1):14–19. doi: 10.1136/jmg.25.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Grimm T. Neugeborenen-Screening nach Duchennescher Muskeldystrophie. Monatsschr Kinderheilkd. 1981 Jul;129(7):414–417. [PubMed] [Google Scholar]
  13. Hanson R., Smith J. A., Hume W. Achievement of infants on items of the Griffiths scales: 1980 compared with 1950. Child Care Health Dev. 1985 Mar-Apr;11(2):91–104. doi: 10.1111/j.1365-2214.1985.tb00454.x. [DOI] [PubMed] [Google Scholar]
  14. Hoffman E. P., Brown R. H., Jr, Kunkel L. M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987 Dec 24;51(6):919–928. doi: 10.1016/0092-8674(87)90579-4. [DOI] [PubMed] [Google Scholar]
  15. Janeway C. A. Screening for inherited diseases. N Engl J Med. 1971 Apr 8;284(14):787–788. doi: 10.1056/NEJM197104082841409. [DOI] [PubMed] [Google Scholar]
  16. Moser H. Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention. Hum Genet. 1984;66(1):17–40. doi: 10.1007/BF00275183. [DOI] [PubMed] [Google Scholar]
  17. Neligan G., Prudham D. Norms for four standard developmental milestones by sex, social class and place in family. Dev Med Child Neurol. 1969 Aug;11(4):413–422. doi: 10.1111/j.1469-8749.1969.tb01459.x. [DOI] [PubMed] [Google Scholar]
  18. O'Brien T., Sibert J. R., Harper P. S. Implications of diagnostic delay in Duchenne muscular dystrophy. Br Med J (Clin Res Ed) 1983 Oct 15;287(6399):1106–1107. doi: 10.1136/bmj.287.6399.1106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Scheuerbrandt G., Lundin A., Lövgren T., Mortier W. Screening for Duchenne muscular dystrophy: an improved screening test for creatine kinase and its application in an infant screening program. Muscle Nerve. 1986 Jan;9(1):11–23. doi: 10.1002/mus.880090103. [DOI] [PubMed] [Google Scholar]
  20. Skinner R., Emery A. E., Scheuerbrandt G., Syme J. Feasibility of neonatal screening for Duchenne muscular dystrophy. J Med Genet. 1982 Feb;19(1):1–3. doi: 10.1136/jmg.19.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Zellweger H., Antonik A. Newborn screening for Duchenne muscular dystrophy. Pediatrics. 1975 Jan;55(1):30–34. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES